Advertisement
Advertisement

BPTH

BPTH logo

Bio-Path Holdings Inc

0.691
USD
-0.003
-0.43%
Dec 18, 13:38 UTC -5
Open

Bio-Path Holdings Inc Profile

About

BIO-PATH is developing leading-edge, patented, liposomal drug delivery systems, with two clinical cancer drug candidates ready for the clinic and a third siRNA cancer drug undergoing final pre-clinical development. Bio-Path's drug delivery technology distributes nucleic acid drugs systemically, throughout the human body, via simple intravenous infusion. The delivery technology can be applied both to double stranded and single stranded nucleic acid compounds with the potential to revolutionize the treatment of cancer and other diseases where drugable targets of disease are well characterized.

Info & Links

CEO

Peter H. Nielsen

Headquarters

4710 BELLAIRE BOULEVARD, SUITE 210
BELLAIRE, TX 77401, UNITED STATES

Industry

Biotechnology

Sector

Health Technology

Website

www.biopathholdings.com

Auditor

Ernst & Young LLP

Share holders

187

Employees

10

Bio-Path Holdings Inc Statistics

Valuation Measures

Market Capitalization2

2.98M

Enterprise Value

2.42M

Enterprise Value/EBITDA(ttm)

-0.20

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

--

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-2842.40%

Return on Invested Capital(ttm)

-492.08%

Return on Assets(ttm)

-337.48%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-12.25M

Net Income Available to Common(ttm)

-10.51M

Diluted EPS(ttm)

--

Share Statistics

Beta (5Y Monthly)

0.23

52-Week Change

-94.07%

S&P 500 52-Week Change

27.89%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

4.31M

Dividend Yield

0.00%

Float4

4.28M

% Held by Insiders

0.72%

% Held by Institutions

5.74%

Balance Sheet

Total Cash(mrq)

562.00K

Total Cash Per Share(mrq)

0.13

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

0.86%

Quick Ratio(mrq)

0.86%

Book Value Per Share(mrq)

-0.19

Cash Flow

Operating Cash Flow Per Share(ytd)

-2.55

Free Cash Flow(ytd)

-7.69M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement